L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome-Reference-Cited by-同舟云学术

L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome

Published:2022-07 Issue: Volume:100 Page:19-23
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Dulski Jarosław,Cerquera-Cleves Catalina,Milanowski Lukasz,Kwiatek-Majkusiak Jolanta,Koziorowski Dariusz,Ross Owen A.,Pentela-Nowicka Jolanta,Sławek Jarosław,Wszolek Zbigniew K.^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference12 articles.

1. Is levodopa response a valid indicator of Parkinson's disease?;Martin;Mov. Disord.,2021

2. Dyskinesia in multiple system atrophy and progressive supranuclear palsy;Jost;J. Neural. Transm. (Vienna),2019

3. Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review;Dulski;Eur. J. Neurol.,2021

4. DCTN1-Related neurodegeneration;Dulski,1993

5. Cognitive and behavioral profile of Perry syndrome in two families;Milanowski;Park. Relat. Disord.,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perry Disease: Bench to Bedside Circulation and a Team Approach;Biomedicines;2024-01-05

2. Perry syndrome: Novel DCTN1 mutation in a large kindred and first observation of prodromal disease;Parkinsonism & Related Disorders;2023-07

3. Perry Disease: Expanding the Genetic Basis;Movement Disorders Clinical Practice;2023-06-22

4. A Chinese pedigree with Perry disease caused by the p.Y78H mutation in DCTN1: A 6-year clinical follow-up;Behavioural Brain Research;2023-03

5. Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines;Neurologia i Neurochirurgia Polska;2023-02-28